Vera Therapeutics, Inc. (VERA) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$112.36M*; Operating income -$112.49M; Depreciation and amortization $132.00K*.
- 2026-03-31: Basis Reported; EBITDA -$124.99M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$94.07M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$83.80M*; Operating income -$83.93M; Depreciation and amortization $129.00K*.
Complete source-backed ebitda history.
- Available history
- 2023-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$112.36M* | -$112.49M | $132.00K* | (m) | (m) | $0.00* | -$100.25M* | (m) | $60.08M | (m) | (m) |
|---|
| 2026-03-31 | Reported | -$124.99M | (m) | (m) | (m) | (m) | $23.00K | -$106.50M | (m) | $86.01M | (m) | (m) |
|---|
| 2025-12-31 | Reported | -$94.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$83.80M* | -$83.93M | $129.00K* | (m) | (m) | $133.00K* | -$61.91M* | (m) | $56.47M | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$80.02M* | -$80.14M | $119.00K* | (m) | (m) | $208.00K* | -$54.80M* | (m) | $58.20M | (m) | (m) |
|---|
| 2025-03-31 | Reported | -$57.11M | (m) | (m) | (m) | (m) | $187.00K | -$54.41M | (m) | $41.28M | (m) | (m) |
|---|
| 2024-12-31 | Reported | -$48.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$49.78M* | -$49.80M | $24.00K* | (m) | (m) | $238.00K* | -$36.88M* | (m) | $40.31M | (m) | (m) |
|---|
| 2024-06-30 | Reported | -$37.33M* | -$37.34M | $15.00K* | (m) | (m) | $89.00K* | -$24.78M* | (m) | $29.31M | (m) | (m) |
|---|
| 2024-03-31 | Reported | -$31.1M | (m) | (m) | (m) | (m) | $0.00 | -$33.83M | (m) | $23.20M | (m) | (m) |
|---|
| 2023-12-31 | Reported | -$27.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$21.75M* | -$21.76M | $6.00K* | (m) | (m) | $0.00* | -$22.97M* | (m) | $16.10M | (m) | (m) |
|---|
| 2023-06-30 | Reported | (m) | -$21.97M | (m) | (m) | (m) | $0.00* | -$17.77M* | (m) | $16.23M | (m) | (m) |
|---|
| 2023-03-31 | Reported | (m) | -$31.26M | (m) | (m) | (m) | $0.00 | -$26.29M | (m) | $25.11M | (m) | (m) |
|---|
| 2022-09-30 | Reported | (m) | -$25.24M | (m) | (m) | (m) | $38.00K* | -$18.42M* | (m) | $19.66M | (m) | $0.00* |
|---|
| 2022-06-30 | Reported | (m) | -$15.06M | (m) | (m) | (m) | $6.00K* | -$19.03M* | (m) | $10.11M | (m) | $0.00* |
|---|
| 2022-03-31 | Reported | (m) | -$17.02M | (m) | (m) | (m) | $18.00K | -$8.98M | (m) | $12.55M | (m) | $0.00 |
|---|
| 2021-09-30 | Reported | (m) | -$7.25M | (m) | (m) | (m) | $0.00* | -$5.48M* | (m) | $3.56M | (m) | $0.00 |
|---|
| 2021-06-30 | Reported | (m) | -$5.85M | (m) | (m) | (m) | $0.00* | -$7.67M* | (m) | $3.23M | (m) | $0.00 |
|---|
| 2021-03-31 | Reported | (m) | -$4.72M | (m) | (m) | (m) | $0.00 | -$4.12M | (m) | $2.93M | (m) | $0.00 |
|---|
| 2020-09-30 | Reported | (m) | -$4.04M | (m) | (m) | (m) | $0.00* | -$2.45M* | (m) | $1.97M | (m) | $0.00 |
|---|
| 2020-06-30 | Reported | (m) | -$3.17M | (m) | (m) | (m) | $47.00K* | -$2.67M* | (m) | $1.95M | (m) | $0.00 |
|---|
| 2020-03-31 | Reported | (m) | -$2.47M | (m) | (m) | (m) | $52.00K | -$2.31M | (m) | $1.44M | (m) | $0.00 |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$315.01M | (m) | (m) | (m) | (m) | $630.00K | -$241.10M | (m) | $215.26M | (m) | $1.00K |
|---|
| 2024-12-31 | Reported | -$167.07M | (m) | (m) | (m) | (m) | $972.00K | -$134.68M | (m) | $126.17M | (m) | $1.00K |
|---|
| 2023-12-31 | Reported | -$101.99M | (m) | (m) | (m) | (m) | $63.00K | -$92.18M | (m) | $78.22M | (m) | $1.00K |
|---|
| 2022-12-31 | Reported | (m) | -$90.90M | (m) | (m) | (m) | $62.00K | -$67.60M | (m) | $68.99M | (m) | $1.00K |
|---|
| 2021-12-31 | Reported | (m) | -$34.40M | (m) | (m) | (m) | $0.00 | -$23.71M | (m) | $22.48M | (m) | $1.00K |
|---|
| 2020-12-31 | Reported | (m) | -$52.24M | (m) | (m) | (m) | $99.00K | -$34.81M | (m) | $45.21M | (m) | -$1.00K |
|---|